Watchlist Price Alert

Tekla Life Sciences Inves... (HQL)

NYSE: HQL · Real-Time Price · USD

12.62

-0.21 (-1.64%)

At close: Jun 17, 2025, 3:59 PM

Tekla Life Sciences Investors Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	n/a	477.00	445.00	990.00	-4.97M	1.12M	41.00	615.31K	10.07K
Short-Term Investments	n/a	15.24M	32.94M	17.17M	4.97M	12.03M	n/a	4.00	9.85M
Long-Term Investments	460.3M	397.53M	414.08M	534.01M	483.97M	381.47M	466.45M	466.98M	370.84M
Other Long-Term Assets	13.9M	n/a	-414.08M	-534.01M	-483.97M	-381.47M	-466.45M	-466.98M	26.67M
Receivables	231.11K	5.04M	623.47K	150.34K	73.9K	4.36M	11.19M	18.13K	10.23M
Inventory	n/a	20.29M	33.57M	17.32M	n/a	17.51M	0.00	10.24M	n/a
Other Current Assets	8.97K	-20.29M	11.09M	8.46M	4.97M	12.03M	13.07M	9.61M	9.85M
Total Current Assets	281.61K	5.05M	623.92K	144.66K	73.9K	5.09M	11.19M	633.44K	20.12M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	474.2M	397.53M	414.08M	534.01M	483.97M	381.47M	466.45M	466.98M	397.51M
Total Assets	460.58M	402.6M	414.73M	534.19M	484.17M	386.98M	478.47M	468.33M	417.63M
Account Payables	1.79K	n/a	5.1M	n/a	n/a	2.82M	2.35M	1.31M	2.1M
Deferred Revenue	n/a	n/a	5.09M	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	12.09K	n/a	n/a	n/a	n/a
Other Current Liabilities	886.82K	n/a	-5.1M	-9.4M	-595.18K	-2.82M	-2.35M	-1.31M	n/a
Total Current Liabilities	888.61K	n/a	5.1M	10.75M	581.24K	2.82M	2.35M	1.31M	2.66M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-1.34M	-12.09K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	5.1M	9.4M	569.15K	3.33M	2.98M	1.98M	2.66M
Total Liabilities	888.61K	666.96K	16.82M	10.75M	595.18K	2.82M	2.98M	1.98M	2.66M
Total Debt	n/a	n/a	11.09K	1.34M	26.03K	n/a	n/a	n/a	n/a
Common Stock	280.61K	267.91K	256.8K	246.68K	238.83K	345.29M	333.78M	317.62M	301.31M
Retained Earnings	44.13M	-1.48M	9.55M	150.7M	127.03M	38.36M	141.71M	-22.5K	-2.73M
Comprehensive Income	n/a	n/a	-0.00	0.00	0.00	-0.00	n/a	148.73M	116.39M
Shareholders Equity	459.69M	401.93M	397.9M	523.44M	483.57M	383.65M	475.49M	466.35M	414.97M
Total Investments	460.3M	397.53M	414.08M	534.01M	483.97M	381.47M	466.45M	466.98M	9.85M